Here are 100 books that Jungle Laboratories fans have personally recommended if you like
Jungle Laboratories.
Book DNA is a community of 12,000+ authors and super readers sharing their favorite books with the world.
Big things have happened long ago and far away. As a kid born into the American Midwest in the Cold War, the world out there seemed like a scary place. But reading was a way to imagine other realities, and from college onward, I have been fortunate enough to encounter people in person and on paper who share their stories if you put in the work and listen. Keeping your ears open, unknown but intelligible worlds of personal contingencies and impersonal forces from other times and places can be glimpsed. How better to begin exploring the communion and conflict than by attending to changes in our practices of eating and medicating?
I found Rappaport’s book to be a really marvelous example of what is now being called “entangled history.” That kind of history picks up one topic and follows it wherever it leads. Because tangible things are easier to trace than intangible things (like ideas or rumors), commodity history is a lively subject, but this is something larger.
Tea has a chemistry to it that people gravitate toward, but there is so much more to the story about why it is so widely consumed in our world today. Once it was a substance grown and sipped in China, but European trading companies also discovered that markets for it could be created. It was famously a commodity deeply entangled in the opium wars, in the new plantation economies of northeastern India and Sri Lanka/Ceylon, and other systems of production.
But Rappaport has so much more to say about the consumption side, too:…
How the global tea industry influenced the international economy and the rise of mass consumerism
Tea has been one of the most popular commodities in the world. For centuries, profits from its growth and sales funded wars and fueled colonization, and its cultivation brought about massive changes-in land use, labor systems, market practices, and social hierarchies-the effects of which are with us even today. A Thirst for Empire takes an in-depth historical look at how men and women-through the tea industry in Europe, Asia, North America, and Africa-transformed global tastes and habits. An expansive and original global history of imperial…
It is April 1st, 2038. Day 60 of China's blockade of the rebel island of Taiwan.
The US government has agreed to provide Taiwan with a weapons system so advanced that it can disrupt the balance of power in the region. But what pilot would be crazy enough to run…
As a historian of science and medicine, I’m fascinated by the many ways that drugs—from tea to opiates, Prozac to psychedelics—have shaped our world. After all, there are few adults on the planet today who don’t regularly consume substances that have been classified as a drug at one time or another (I’m looking at you, coffee and tea!). The books I’ve selected here have deeply influenced my own thinking on the history of drugs over the past decade, from my first book, The Age of Intoxication, to my new book on the history of psychedelic science.
In this tour-de-force work of investigative journalism, New Yorker staff writer Patrick Radden Keefe traces the sordid history of the Sackler dynasty, the billionaire family behind Purdue Pharmaceuticals and its blockbuster narcotic painkiller OxyContin.
With both narrative verve and moral urgency—a combination that isn’t always easy to pull off—this book exposes one of the many points of origin for America’s devastating opioid epidemic. Keefe’s work has reinforced my conviction that drug historians have an important role to play in shaping public understanding and policy debates around these substances in the present. I found this book to be a page-turner and one of the most thoughtful books I’ve read in years.
NEW YORK TIMES BESTSELLER • A NEW YORK TIMES NOTABLE BOOK OF THE YEAR • A grand, devastating portrait of three generations of the Sackler family, famed for their philanthropy, whose fortune was built by Valium and whose reputation was destroyed by OxyContin. From the prize-winning and bestselling author of Say Nothing.
"A real-life version of the HBO series Succession with a lethal sting in its tail…a masterful work of narrative reportage.” – Laura Miller, Slate
The history of the Sackler dynasty is rife with drama—baroque personal lives; bitter disputes over estates; fistfights in boardrooms; glittering art collections; Machiavellian courtroom…
As a historian of science and medicine, I’m fascinated by the many ways that drugs—from tea to opiates, Prozac to psychedelics—have shaped our world. After all, there are few adults on the planet today who don’t regularly consume substances that have been classified as a drug at one time or another (I’m looking at you, coffee and tea!). The books I’ve selected here have deeply influenced my own thinking on the history of drugs over the past decade, from my first book, The Age of Intoxication, to my new book on the history of psychedelic science.
If I were asked to recommend just one book on the history of drugs, this would be it. Courtwright is an expert in the history of drugs in the nineteenth and twentieth-century United States, but in this book, he zooms out—way out—to think about the larger history of humanity’s relationship to mind-altering substances.
At the book's core is Courtwright’s influential concept of a “psychoactive revolution” that influenced the histories of empire, globalization, and science over the past five centuries. I have been deeply influenced by his approach ever since I first read this book in grad school, and I use it often in my teaching.
What drives the drug trade, and how has it come to be what it is today? A global history of the acquisition of progressively more potent means of altering ordinary waking consciousness, this book is the first to provide the big picture of the discovery, interchange, and exploitation of the planet's psychoactive resources, from tea and kola to opiates and amphetamines.
The Year Mrs. Cooper Got Out More
by
Meredith Marple,
The coastal tourist town of Great Wharf, Maine, boasts a crime rate so low you might suspect someone’s lying.
Nevertheless, jobless empty nester Mallory Cooper has become increasingly reclusive and fearful. Careful to keep the red wine handy and loath to leave the house, Mallory misses her happier self—and so…
As a historian of science and medicine, I’m fascinated by the many ways that drugs—from tea to opiates, Prozac to psychedelics—have shaped our world. After all, there are few adults on the planet today who don’t regularly consume substances that have been classified as a drug at one time or another (I’m looking at you, coffee and tea!). The books I’ve selected here have deeply influenced my own thinking on the history of drugs over the past decade, from my first book, The Age of Intoxication, to my new book on the history of psychedelic science.
Mike Jay is the best writer I know of when it comes to highlighting the human stories behind the history of drugs. He is also fabulously engaging and original.
Jay’s most recent book is a compelling history of self-experimentation with drugs, which ranges from Romantic-era opium eaters like Thomas de Quincey to pioneer neuroscientists and Siberian shamans—and, of course, the hilariously weird nitrous oxide experiments of William James, who graces the book’s cover.
"Richly detailed and frequently illuminating."-Rhys Blakely, Times (UK)
"Excellent."-Clare Bucknell, New Yorker
A New Yorker Best of the Week Pick
A provocative and original history of the scientists and writers, artists and philosophers who took drugs to explore the hidden regions of the mind
Until the twentieth century, scientists investigating the effects of drugs on the mind did so by experimenting on themselves. Vivid descriptions of drug experiences sparked insights across the mind sciences, pharmacology, medicine, and philosophy. Accounts in journals and literary fiction inspired a fascinated public to make their own experiments-in scientific demonstrations,…
I am a medical thriller author who, during a brief stint in residency after medical school, saw up close what the world of medicine is really like, from the level of the patient at the bedside to the industrial level with big corporate players such as pharmaceutical and health insurance companies. I am in a position to curate what books can inform the general public about such topics.
I have always known that problems can potentially occur with pharmaceutical drugs, even when regulations are in place. But when there is a black market for dangerous counterfeit versions of those drugs, the risk to patient safety skyrockets.
I liked how this book opened my eyes to this global phenomenon that is more common than one might think.
Long the scourge of developing countries, fake pills are now increasingly common in the United States. The explosion of Internet commerce, coupled with globalization and increased pharmaceutical use has led to an unprecedented vulnerability in the U.S. drug supply. Today, an estimated 80% of our drugs are manufactured overseas, mostly in India and China. Every link along this supply chain offers an opportunity for counterfeiters, and increasingly, they are breaking in. In 2008, fake doses of the blood thinner Heparin killed 81 people worldwide and resulted in hundreds of severe allergic reactions in the United States. In 2012, a counterfeit…
Frank S. David, MD, PhD leads the biopharma consulting firm Pharmagellan, where he advises drug companies and investors on R&D and business strategy. He is also an academic researcher on strategy, regulation, and policy in the drug industry; a member of the Harvard-MIT Center for Regulatory Science; and a former blogger at Forbes.com.
A key issue about drug pricing not covered in Kolchinsky's book relates to value: even if a new therapy is affordable, is it "worth it"? Health economist Peter Neumann and his colleagues have written an authoritative, insightful, and extremely accessible history of efforts to align drugs' prices with their benefits to patients and society. This is a must-read guide for both insiders and non-experts to a topic that will be at the forefront of the drug pricing debate in the coming decade.
The US prescription drug business is a $500 billion industry whose rising prices carry profound consequences for patients, caregivers, employers and taxpayers across the nation. In the United States, average prices of leading brand-name drugs are two to four times higher than prices charged in other wealthy countries, raising questions as to what Americans are getting for the extra expense. On the other hand, healthy industry returns have arguably fueled life-saving innovation. With the advent of ever more targeted and powerful treatments, including cell- and gene-based therapies with multi-million-dollar price tags, the need for sensible drug pricing policies will only…
Don’t mess with the hothead—or he might just mess with you. Slater Ibáñez is only interested in two kinds of guys: the ones he wants to punch, and the ones he sleeps with. Things get interesting when they start to overlap. A freelance investigator, Slater trolls the dark side of…
I am a medical thriller author who, during a brief stint in residency after medical school, saw up close what the world of medicine is really like, from the level of the patient at the bedside to the industrial level with big corporate players such as pharmaceutical and health insurance companies. I am in a position to curate what books can inform the general public about such topics.
If you already dislike the pharmaceutical industry for whatever reason, this book could certainly make your blood boil further.
In an effort to get a diverse perspective on Big Pharma, I made sure to check out a book with a contrary opinion, and this one fit the bill. I came away with a greater awareness of the industry’s impacts that are widespread globally, not locally.
In Pharmanomics, investigative journalist Nick Dearden digs down into the way we produce our medicines and finds that Big Pharma is failing us, with catastrophic consequences.
Big Pharma is more interested in profit than health. This was made clear as governments rushed to produce vaccines during the Covid pandemic. Behind the much-trumpeted scientific breakthroughs, major companies found new ways of gouging billions from governments in the West while abandoning the Global South. But this is only the latest episode in a long history of financialising medicine - from Purdue's rapacious marketing of highly addictive…
Frank S. David, MD, PhD leads the biopharma consulting firm Pharmagellan, where he advises drug companies and investors on R&D and business strategy. He is also an academic researcher on strategy, regulation, and policy in the drug industry; a member of the Harvard-MIT Center for Regulatory Science; and a former blogger at Forbes.com.
This account of the early years of Vertex Pharmaceuticals, from its inception as a scrappy start-up to its early work in HIV, is a must-read classic for anyone interested in how science turns into new drugs. Barry Werth’s journalistic play-by-play is a cinematic, true-to-life picture of the strategic decisions, real-world challenges, and larger-than-life personalities that underlie modern drug development. His riveting follow-up, The Antidote, continues the saga by taking readers through Vertex’s pathbreaking work to transform the care of patients with hepatitis C and cystic fibrosis.
I am a medical thriller author who, during a brief stint in residency after medical school, saw up close what the world of medicine is really like, from the level of the patient at the bedside to the industrial level with big corporate players such as pharmaceutical and health insurance companies. I am in a position to curate what books can inform the general public about such topics.
There is a reason that the U.S. Food and Drug Administration exists: the pre-FDA era of medicine was the Wild West of healing.
As someone who already had some understanding of the FDA’s processes, this book expanded on that knowledge. At the same time, I appreciated how this book can be a breathtaking introduction to the FDA with no prior knowledge of it.
How the FDA was shaped by public health crises and patient advocacy, told against a background of the contentious hearings on the breast cancer drug Avastin.
Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer’s drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate US authority on a drug’s safety and efficacy? In Drugs and the FDA, Mikkael Sekeres—a leading oncologist and former chair of the FDA’s cancer drug advisory committee—tells the story of how the FDA became the most trusted regulatory agency…
In my younger days, as the son of a medical professor and a public health nurse, I was more interested in healing society than patients. But my political interests and research agenda as a professor of political science ultimately led back to medicine. I found that profit-maximizing market competition in health care failed miserably to promote value in therapeutics and economize on society’s scarce resources. I became aware of the neglect of public health to prevent disease for vulnerable groups in society and save money as well as lives. Pervasive and enduring economic conflicts of interest in the medical-industrial complex bear primary responsibility for severe deficits in quality, equality, and economy in American health care.
I found, as a history buff, The Struggle for Drug Reform to be an eye-opener about how America’s exceptionally high drug prices among other deficits in health care quality and coverage resulted from the past exercise of power by the pharmaceutical industry, the lynchpin of America’s “medico-industrial complex.”
I was impressed by historian Tobbell’s meticulously researched account of the industry’s strategic alliances with self-interested medical scientists, not just conservative political forces, and its use of anti-communist propaganda to fight off the threat of drug pricing regulations.
I personally found important her discussions of how the industry allied with the American Medical Association against universal health care, against FDA demands for evidence about drug efficacy and safety before allowing drugs on the market, and against the threat to its profits from generic drugs.
Since the 1950s, the American pharmaceutical industry has been heavily criticized for its profit levels, the high cost of prescription drugs, drug safety problems, and more, yet it has, together with the medical profession, staunchly and successfully opposed regulation. "Pills, Power, and Policy" offers a lucid history of how the American drug industry and key sectors of the medical profession came to be allies against pharmaceutical reform. It details the political strategies they have used to influence public opinion, shape legislative reform, and define the regulatory environment of prescription drugs. Untangling the complex relationships between drug companies, physicians, and academic…
